Chapel Hill, N.C. -- A U.S. study has identified a tumor suppressor gene known as LKB1 that is mutated in nearly a quarter of all human lung cancers.
Although cancer causing mutations occur in our bodies every day, humans have specific genes that recognize such malignant events and keep cells from growing out of control, researchers said. But only a few such tumor suppressors are currently known.
Now scientists at the University of North Carolina at Chapel Hill School of Medicine and Harvard Medical School have found mutations of LKB1 in mice result in tumors that are more aggressive and more likely to spread throughout the body.
"Defects in this gene appear to result in a much nastier form of lung cancer, a disease that is bad to begin with," said Dr. Norman Sharpless, an assistant professor of medicine and senior author of the study.
The finding is expected to help physicians better assign a prognosis to their patients, as well as giving them a new target for future therapies, Sharpless said.
The study, published online in the journal Nature, also presents the first mouse model of the most lethal malignancy in man, a form of lung cancer called squamous cell carcinoma.
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
8 hours 51 min ago
16 hours 5 min ago
21 hours 10 min ago
1 day 3 hours ago
2 days 13 hours ago
2 days 18 hours ago
2 days 23 hours ago
2 days 23 hours ago
3 days 11 hours ago
3 days 23 hours ago